PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Adrenal and Hypertension Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, São Paulo, Brazil.\', \'Corpometria Institute, Brasilia, Distrito Federal, Brazil.\', \'Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.\', \'Applied Biology Inc, Irvine, California, USA.\', \'Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA carlos_wambier@brown.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e24157210.1136/bcr-2021-241572
?:hasPublicationType
?:journal
  • BMJ case reports
is ?:pmid of
?:pmid
?:pmid
  • 33637513
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.213
?:rankingScore_hIndex
  • 17
is ?:relation_isRelatedTo_publication of
?:title
  • Potential risk for developing severe COVID-19 disease among anabolic steroid users.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33637513>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33637513>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all